Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 1,6411,660 of 20,252 grants

Active OTHER RESEARCH-RELATED
CaREER: Cancer Research Education Excellence in Radiotherapy
NATIONAL CANCER INSTITUTE Johns Hopkins University United States 2024 – 2029

Project Abstract Radiotherapy (RT) is used in the treatment of over 50% of cancer patients. Despite major technological developments, RT is still critically limited by normal tissu...

$3.24M
USD
Completed NON-SBIR/STTR RPGS
Elucidation of a novel transcriptional reprogramming-induced mechanism of endocrine resistance and therapeutic targeting
NATIONAL CANCER INSTITUTE Wayne State University United States 2024 – 2026

ABSTRACT Breast cancer is the most common cancer and the second leading cause of cancer mortality in women in the U.S. Approximately 75% of breast cancers are estrogen receptor  (...

$1.8M
USD
Active NON-SBIR/STTR RPGS
The oral-gut axis in colorectal cancer
NATIONAL CANCER INSTITUTE University of Michigan At Ann Arbor United States 2024 – 2029

PROJECT SUMMARY/ABSTRACT: Microbes have been implicated in colorectal cancer (CRC) pathogenesis, but definitive knowledge awaits of the identities of contributing microbes and thei...

$5.81M
USD
Active NON-SBIR/STTR RPGS
A compact beam delivery system enabling ultra-fast dose delivery for upright proton therapy
NATIONAL CANCER INSTITUTE Massachusetts General Hospital United States 2024 – 2029

Project Summary/Abstract This project aims to develop a compact fixed beamline solution incorporating Fixed-Field Alternating Gradient (FFA) technology and a novel ultra-fast energ...

$5M
USD
Active NON-SBIR/STTR RPGS
Neoadjuvant Tucatinib plus Trastuzumab in HER2-amplified Locally Advanced Rectal Cancer
NATIONAL CANCER INSTITUTE Sloan-Kettering Inst Can Research United States 2024 – 2029

PROJECT SUMMARY/ABSTRACT Current standard tri-modality therapy (chemotherapy, radiation, and surgery) for locally advanced rectal cancer is associated with high morbidity and only...

$4.03M
USD
Active NON-SBIR/STTR RPGS
Molecular features promoting sensitivity to LSD1i in castration-resistant prostate cancer
NATIONAL CANCER INSTITUTE Johns Hopkins University United States 2024 – 2029

Prostate cancer (PCa) remains an incurable disease once progression to the metastatic castration-resistant (mCRPC) state occurs; killing >30,000 U.S. men/yr. Unfortunately, each...

$6.07M
USD
Active NON-SBIR/STTR RPGS
Identifying molecular vulnerabilities of ALT-dependent cancers
NATIONAL CANCER INSTITUTE Weill Medical Coll of Cornell Univ United States 2024 – 2029

PROJECT SUMMARY Telomeres are specialized protein-DNA structures that protect the ends of linear chromosomes and maintain genomic stability. Maintenance of adequate telomere length...

$3.88M
USD
Active NON-SBIR/STTR RPGS
Targeting dsRNA sensing and ADAR1 in melanoma
NATIONAL CANCER INSTITUTE Yale University United States 2024 – 2029

PROJECT SUMMARY: Over the past decade the development of immune checkpoint blockade (ICB) in melanoma and other tumor types has transformed the treatment options available for many...

$6.32M
USD
Active NON-SBIR/STTR RPGS
Improving risk stratification for lung cancer screening using peripheral blood leukocyte DNA methylation: an investigation in the National Lung Screening Trial (NLST)
NATIONAL CANCER INSTITUTE Tufts University Boston United States 2024 – 2028

Project Summary Lung cancer is the leading cause of cancer death in the US, accounting for approximately 22% of all cancer deaths. Annual screening with low-dose computed tomograph...

$7.22M
USD
Active NON-SBIR/STTR RPGS
A Real-Time Hyperspectral Laparoscopic Stereo Imaging System for Robot-Assisted Surgery
NATIONAL CANCER INSTITUTE University of Texas Dallas United States 2024 – 2029

Faster recovery, reduced hospital stays, and a quicker return to normal activities are the most evident advantages of laparoscopic surgery. More than 13 million laparoscopic proced...

$5.89M
USD
Active NON-SBIR/STTR RPGS
Exploiting A Critical Vulnerability To Glutamine Antimetabolite Therapy in Fibrolamellar Hepatocellular Carcinoma (FLC)
NATIONAL CANCER INSTITUTE Johns Hopkins University United States 2024 – 2029

Project Abstract Fibrolamellar hepatocellular carcinoma (FLC) is a rare and often lethal form of liver cancer that primarily affects children and young adults without cirrhosis. Th...

$6.5M
USD
Active NON-SBIR/STTR RPGS
Orally active CBP/p300 degraders
NATIONAL CANCER INSTITUTE University of Michigan At Ann Arbor United States 2024 – 2029

Abstract: The histone acetyltransferase CREB-binding protein (CBP) and its paralogue p300 protein are key transcriptional co-activators and attractive therapeutic targets for human...

$6.88M
USD
Completed NON-SBIR/STTR RPGS
Mini-gantry for proton therapy
NATIONAL CANCER INSTITUTE Massachusetts General Hospital United States 2024 – 2026

ABSTRACT We hypothesize that a room-temperature, 360°, isocentric proton therapy gantry fits inside a Linac vault, a.k.a the Mini-Gantry. This would enable the conversion of two ne...

$835K
USD
Active NON-SBIR/STTR RPGS
Overcoming Therapy Resistance in SCLC
NATIONAL CANCER INSTITUTE Ut Southwestern Medical Center United States 2024 – 2029

PROJECT SUMMARY/ABSTRACT Small cell lungcancer (SCLC) is a pulmonary neuroendocrine cancer with very poor prognosis and limited effective therapeutic options. Chemotherapy has been...

$5M
USD
Active NON-SBIR/STTR RPGS
Analyzing DNA replication and damage vulnerability in IDH mutant glioma
NATIONAL CANCER INSTITUTE Massachusetts General Hospital United States 2024 – 2029

Project Summary Adult diffuse gliomas that harbor mutations in the metabolic enzyme isocitrate dehydrogenase 1 (IDH1) are common in younger adults, and universally evade the curren...

$3.97M
USD
Active NON-SBIR/STTR RPGS
Hepatic Tissue Integrity and Clonal Fitness: Key Factors in Controlling β-Catenin Induced Oncogenesis
NATIONAL CANCER INSTITUTE Research Inst of Fox Chase Can Ctr United States 2024 – 2029

PROJECT SUMMARY Given the importance of mutations in oncogenes and tumor suppressor genes, it has been widely assumed that the mere accumulation of mutations is the primary process...

$6.02M
USD
Completed NON-SBIR/STTR RPGS
A Novel Strategy of Targeting Transmembrane Protein to Improve KRAS-targeted Therapy
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2024 – 2026

Project Summary/Abstract Pancreatic cancer is the most common form of pancreatic cancer and is currently incurable. Unraveling essential cellular reprograming required for PDAC dev...

$2.14M
USD
Active NON-SBIR/STTR RPGS
Melanoma Resistance Evolution Atlas (MREA) for identifying combinatorial targets to prevent and reverse MAPKi resistance
NATIONAL CANCER INSTITUTE University of California Los Angeles United States 2024 – 2029

Project Summary The benefit of MAPK inhibitor (MAPKi) therapy for melanoma has been limited to patients with BRAFV600 mutant melanoma. Since the development of MEK inhibitor (MEKi)...

$6.61M
USD
Active NON-SBIR/STTR RPGS
Mechanisms and therapeutic targeting of lethal prostate cancer master regulator transcription factors
NATIONAL CANCER INSTITUTE Mayo Clinic Rochester United States 2024 – 2029

SUMMARY Prostate cancer (PCa) is the most frequent malignancy and a leading cause of cancer death in men in the United States. Once PCa progresses to an advanced metastatic therapy...

$5.33M
USD
Completed NON-SBIR/STTR RPGS
Combined inhibition of ATR and p110β as Therapy in PTEN-deficient Prostate Cancer
NATIONAL CANCER INSTITUTE Roswell Park Cancer Institute Corp United States 2024 – 2026

Project Summary/Abstract Given the high mortality of castration-resistant prostate cancer (CRPC) as a result of relapse after androgen deprivation therapy (ADT), novel treatment st...

$2.03M
USD